New vaccine to protect cattle from deadly tick-borne disease developed by Mizzou researchers
The research team created the vaccine by genetically modifying the Anaplasma marginale pathogen, successfully immunizing cattle from bovine anaplasmosis..
The research team created the vaccine by genetically modifying the Anaplasma marginale pathogen, successfully immunizing cattle from bovine anaplasmosis..
Dr. Finn shares about the cases he sees in his practice, how he integrates the first USDA-conditionally approved Canine Parvovirus Monoclonal Antibody (CPMA) treatment to handle parvo cases, and his social media work.
The goal is to ensure veterinarians help in minimizing the development of antimicrobial resistance (AMR), protecting our patients, and the future health of other animals, people, and the environment.
Felanorm, with active ingredient methimazole, is supplied in 30 mL or 100 mL bottles, with a 1 mL dosing syringe for treatment of feline hyperthyroidism.
The compounded medication, GS-441524, is now available in a quad-scored, 50-mg tuna-flavored tablet and can be prescribed to manage feline infectious peritonitis (FIP)
Acting uncritically on promotional claims and other information supplied by the marketing company may lead to inadequate or misinformed prescribing decisions.
The off-the-shelf product is intended to provide a canine-specific source of concentrated platelets in plasma for intra-articular administration in dogs.
An extended-release buprenorphine injectable suspension indicated for mice, rats, ferrets, Ethiqa XR gets the U.S. Food and Drug Administration (FDA) green light for use in non-human primates (NHPs)
Extended antibiotic therapy is not an unreasonable idea. New research is whittling away the recommended duration of antibiotics for canine aspiration pneumonia. Is there, in fact, good evidence for recommendations for long duration of antibiotic therapy for aspiration pneumonia?
The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M